(S)-1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propan-1-amine | 59592-33-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: (S)-1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propan-1-amine
• 英文别名: 1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propan-1-amine；1-(1H-benzimidazol-2-yl)-3-(methylsulfanyl)propan-1-amine；(1S)-1-(1H-benzimidazol-2-yl)-3-methylsulfanylpropan-1-amine
• CAS: 59592-33-5
• 化学式: C₁₁H₁₅N₃S
• mdl: MFCD09863481
• 分子量: 221.326
• InChiKey: WWNOVKZOKFLYAF-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  80
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propan-1-amine 、 3,5-双(三氟甲基)苯基异硫氰酯 以 四氢呋喃 为溶剂， 反应 24.0h， 以65%的产率得到1-(1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea
  参考文献：
  名称：

  Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors

  摘要：

  A new series of chiral thiourea derivatives (5a-5c) and thiourea containing benzimidazole moieties (9b-9e) were synthesized from different amino acids (L-valine, L-isoleucine, L-methionine, L-phenylalanine, and D-phenylglycine). The compounds were characterized and tested against the two most studied members of the pH regulatory enzyme family, carbonic anhydrase (CA, EC 4.2.1.1). K-I values of the novel compounds were measured in the range of 3.4-73.6 mu M for hCA I isozyme and 8.7-1.44.2 mu M for hCA II isozyme, respectively. Phenol was also tested as standard in order to understand the structure activity relationship and the clinically used sulfonamide acetazolamide was tested for comparison reasons. All of the compounds exhibited competitive inhibition with 4-nitrophenylacetate as substrate.

  DOI：

  10.3109/14756366.2013.879656
• 作为产物：
  描述：

  Boc-L-蛋氨酸 在 盐酸 、 1-羟基苯并三唑 、 溶剂黄146 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 (S)-1-(1H-benzo[d]imidazol-2-yl)-3-(methylthio)propan-1-amine
  参考文献：
  名称：

  新型底物竞争性赖氨酸甲基转移酶 G9a 抑制剂作为抗癌药物的发现

  摘要：

  结构新颖的赖氨酸甲基转移酶 G9a 抑制剂的鉴定一直是癌症表观遗传学研究的重点。以东京大学药物发现计划化学图书馆获得的高通量筛选（HTS）命中的rac - 10a为起点，借助X射线晶体学建立了独特底物竞争性抑制剂的构效关系和片段分子轨道（FMO）计算配体-蛋白质相互作用。体外特性以及药物代谢和药代动力学 (DMPK) 特性的进一步优化导致了26j (RK-701) 的鉴定，它是一种结构独特的 G9a/GLP 强效抑制剂 (IC 50 = 27/53 nM)。化合物26j对其他相关甲基转移酶表现出显着的选择性，对细胞 H3K9me2 水平具有剂量依赖性减弱作用，并且在体外对 MOLT-4 细胞中的肿瘤生长具有抑制作用。此外，化合物26j在致癌物诱导的肝细胞癌 (HCC)体内小鼠模型中显示出对肿瘤发生和生长的抑制作用，且没有明显的急性毒性。

  DOI：

  10.1021/acs.jmedchem.2c02059

文献信息

• Synthesis of Benzimidazoles from Amino Acids with Solvent-free Melting Method
  作者：Ren-Hong Chen、Jin-Feng Xiong、Pai Peng、Guang-Zhen Mo、Xing-San Tang、Zhao-Yang Wang、Xiu-Fang Wang

  DOI：10.14233/ajchem.2014.16438

  日期：——

  By using low cost and readily available amino acids as the synthetic blocks, a series of 2-aminomethyl-benzimidazole are synthesized with solvent-free melting method. While the condensation of aspartic acid (or asparagine) with o-diaminobenzene gives the fluorescent bisbenzimidazole product without amino group via the further deamination reaction in the melting reaction system. The condensation reactions between most amino acids and o-diaminobenzenes exhibits higher yields of 58 to 86 % (mostly over 66 %), shorter reaction time (5 h) than that previously reported and better tolerance for different functional groups in amino acids. The structures of twenty benzimidazoles with multifunctional groups, including thirteen new compounds, are systematically characterized with FTIR, 1H NMR, 13C NMR, MS and elemental analysis. These investigations are beneficial to the further researches on their applications in biochemistry, coordination chemistry and organic synthesis intermediates.

  利用低成本且易获取的氨基酸作为合成模块，通过无溶剂熔融法合成了一系列2-氨基甲基苯并咪唑。将天冬氨酸（或天冬酰胺）与邻二氨基苯缩合，在熔融反应体系中通过进一步的脱氨基反应得到了无氨基的发光双苯并咪唑产物。大多数氨基酸与邻二氨基苯的缩合反应表现出更高的产率（58%至86%，大多超过66%），反应时间更短（5小时），并且对氨基酸中的不同官能团具有更好的耐受性。通过FTIR、1H NMR、13C NMR、MS和元素分析系统地表征了含有多官能团的二十种苯并咪唑的结构，其中包括十三种新化合物。这些研究有利于进一步探索它们在生物化学、配位化学和有机合成中间体中的应用。
• Insight into the corrosion mitigation performance of three novel benzimidazole derivatives of amino acids for carbon steel (X56) in 1 M HCl solution
  作者：Qahtan A. Yousif、Zainb Fadel、Ahmed M. Abuelela、Eid H. Alosaimi、Saad Melhi、Mahmoud A. Bedair

  DOI：10.1039/d3ra01837g

  日期：——

  Three organic molecules having benzimidazole were synthesized and used for protection of carbon steel (X56) from corrosion in 1.00 M HCl. They showed a maximum protective efficiency range between 95% and 98% indicating high corrosion inhibition.

  合成了三种含有苯并咪唑的有机分子，用于保护碳钢（X56）免受 1.00 M HCl 的腐蚀。它们的最大保护效率介于 95% 和 98% 之间，表明它们具有很强的腐蚀抑制能力。
• Discovery of small molecule human FPR1 receptor antagonists
  作者：John Unitt、Malbinder Fagura、Tim Phillips、Sarah King、Matthew Perry、Andrew Morley、Cathy MacDonald、Richard Weaver、Jadeen Christie、Simon Barber、Rukhsana Mohammed、Melanie Paul、Andrew Cook、Andrew Baxter

  DOI：10.1016/j.bmcl.2011.03.049

  日期：2011.5

  The identification of two novel series of formyl peptide receptor 1 (FPR1) antagonists are reported, represented by methionine benzimidazole 6 and diamide 7. Both series specifically inhibited the binding of labelled fMLF to hrFPR1 and selectively antagonized FPR1 function in human neutrophils, making them useful in vitro validation tools for the target. (C) 2011 Elsevier Ltd. All rights reserved.
• Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors
  作者：Neslihan Korkmaz、Oday A. Obaidi、Murat Senturk、Demet Astley、Deniz Ekinci、Claudiu T. Supuran

  DOI：10.3109/14756366.2013.879656

  日期：2015.1.2

  A new series of chiral thiourea derivatives (5a-5c) and thiourea containing benzimidazole moieties (9b-9e) were synthesized from different amino acids (L-valine, L-isoleucine, L-methionine, L-phenylalanine, and D-phenylglycine). The compounds were characterized and tested against the two most studied members of the pH regulatory enzyme family, carbonic anhydrase (CA, EC 4.2.1.1). K-I values of the novel compounds were measured in the range of 3.4-73.6 mu M for hCA I isozyme and 8.7-1.44.2 mu M for hCA II isozyme, respectively. Phenol was also tested as standard in order to understand the structure activity relationship and the clinically used sulfonamide acetazolamide was tested for comparison reasons. All of the compounds exhibited competitive inhibition with 4-nitrophenylacetate as substrate.
• Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents
  作者：Yosuke Nishigaya、Shohei Takase、Tatsunobu Sumiya、Ko Kikuzato、Tomohiro Sato、Hideaki Niwa、Shin Sato、Akiko Nakata、Takeshi Sonoda、Noriaki Hashimoto、Ryosuke Namie、Teruki Honma、Takashi Umehara、Mikako Shirouzu、Hiroo Koyama、Minoru Yoshida、Akihiro Ito、Fumiyuki Shirai

  DOI：10.1021/acs.jmedchem.2c02059

  日期：2023.3.23

  Identification of structurally novel inhibitors of lysine methyltransferase G9a has been a subject of intense research in cancer epigenetics. Starting with the high-throughput screening (HTS) hit rac-10a obtained from the chemical library of the University of Tokyo Drug Discovery Initiative, the structure–activity relationship of the unique substrate-competitive inhibitors was established with the

  结构新颖的赖氨酸甲基转移酶 G9a 抑制剂的鉴定一直是癌症表观遗传学研究的重点。以东京大学药物发现计划化学图书馆获得的高通量筛选（HTS）命中的rac - 10a为起点，借助X射线晶体学建立了独特底物竞争性抑制剂的构效关系和片段分子轨道（FMO）计算配体-蛋白质相互作用。体外特性以及药物代谢和药代动力学 (DMPK) 特性的进一步优化导致了26j (RK-701) 的鉴定，它是一种结构独特的 G9a/GLP 强效抑制剂 (IC 50 = 27/53 nM)。化合物26j对其他相关甲基转移酶表现出显着的选择性，对细胞 H3K9me2 水平具有剂量依赖性减弱作用，并且在体外对 MOLT-4 细胞中的肿瘤生长具有抑制作用。此外，化合物26j在致癌物诱导的肝细胞癌 (HCC)体内小鼠模型中显示出对肿瘤发生和生长的抑制作用，且没有明显的急性毒性。